Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Valeant Pharmaceuticals International Inc. (T.BHC) had Gross Margin of 72.03% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
246.59M |
|
-- |
|
-- |
|
-- |
|
852.73M |
|
-- |
|
300.32M |
|
300.32M |
|
249.35M |
|
249.35M |
|
249.35M |
|
249.35M |
|
852.73M |
|
1.29B |
|
371.30M |
|
375.50M |
|
0.66 |
|
0.66 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
36.95B |
|
-- |
|
-- |
|
-- |
|
36.46B |
|
490.43M |
|
-21.71B |
|
490.43M |
|
370.47M |
|
| Cash Flow Statement Financials | |
1.25B |
|
-431.19M |
|
-698.44M |
|
1.65B |
|
1.85B |
|
191.49M |
|
181.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.30 |
|
-- |
|
-- |
|
0.98 |
|
59.11 |
|
|
Gross Margin |
72.03% |
23.09% |
|
23.09% |
|
-- |
|
8.13% |
|
6.68% |
|
826.56M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.47 |
|
1.11 |
|
81.14 |
|
50.84% |
|
-1.15% |
|
0.67% |
|
0.87% |
|
1.32 |
|
2.20 |
|
3.32 |
|